Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/10050713

Download in:

View as

General Info

PMID
10050713